What Is Tirzepatide?
Tirzepatide is a dual incretin receptor agonist — simultaneously activating both the GIP (glucose-dependent insulinotropic polypeptide) receptor and the GLP-1 (glucagon-like peptide-1) receptor. This dual mechanism distinguishes it from selective GLP-1 agonists like Semaglutide, and makes it a distinct research subject for studying the additive or synergistic effects of concurrent GIPR and GLP-1R activation.
Preclinical research has examined Tirzepatide in models of insulin secretion, glucagon suppression, gastric motility, hypothalamic appetite regulation, and adipose tissue metabolism. For researchers studying the progression from dual to triple agonism, Eternal Peptides Wholesale also stocks Retatrutide — a GIP/GLP-1/glucagon triple agonist.
This page covers procurement. For GLP-1 selective agonist research, see Semaglutide. For triple agonist research, see Retatrutide. For research use only.
Tirzepatide Products
Supplied as lyophilised powder in boxes of 10 research-grade vials.
Why Researchers Choose Eternal Peptides
Janoshik-Verified Every Batch
HPLC purity, mass spectrometry identity, sterility (USP), endotoxin (LAL), and heavy metals (ICP-MS). COAs published on each product page. Independently verifiable at janoshik.com.
Australian-Owned, ABN Registered
ABN-registered Australian business dispatching domestically. ABN shown on all invoices.
Wholesale Box Pricing
Supplied in boxes of 10 vials at wholesale pricing. Structured for research procurement budgets.
1-2 Day Dispatch
Orders dispatched within 1-2 business days from Australia. COA included with every order.
Frequently Asked Questions
Where can I buy Tirzepatide in Australia? +
Eternal Peptides Wholesale is an Australian-owned, ABN-registered distributor supplying Tirzepatide for research purposes. TR10 (10mg, box of 10) is $396.00. Janoshik-verified with COAs on each product page. Dispatched from Australia within 1-2 business days. For research use only.
What is Tirzepatide used for in research? +
Tirzepatide is studied in metabolic models including insulin secretion, glucagon suppression, appetite regulation, gastric motility, and adipose tissue metabolism. The dual GIP/GLP-1 mechanism enables research into the additive effects of simultaneous incretin receptor co-activation. For research use only.
How does Tirzepatide compare to Semaglutide? +
Semaglutide selectively targets the GLP-1 receptor. Tirzepatide adds co-agonism at the GIP receptor, providing dual incretin activation. Preclinical comparisons have shown additive effects on metabolic endpoints attributable to GIPR activation. Both are available from Eternal Peptides Wholesale. See the Semaglutide page. For research use only.
How does Tirzepatide compare to Retatrutide? +
Tirzepatide is a dual GIP/GLP-1 agonist. Retatrutide adds a third mechanism via glucagon receptor agonism, studied for thermogenic and hepatic lipid effects. Eternal Peptides Wholesale stocks Retatrutide as RT10 ($544.50) and RT20 ($891.00). See the Retatrutide page. For research use only.
How is Tirzepatide quality verified? +
Every batch is tested by Janoshik Analytical — HPLC purity, mass spectrometry identity, sterility (USP), endotoxin (LAL), heavy metals (ICP-MS). COA published on the product page, independently verifiable at janoshik.com. For research use only.
How quickly is Tirzepatide dispatched? +
Orders are dispatched within 1-2 business days of payment confirmation from Australia. COA documentation is included with every order.